Evidence map›Paper›PMID 40382142›Full record

ArticleMethods in enzymology2025

Monitoring ODC activity and polyamines in Bachmann-Bupp syndrome patient biological samples.

Chad R Schultz, Elizabeth A VanSickle, Caleb P Bupp, André S Bachmann

Abstract read
In one paragraph

Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chad R SchultzDepartment of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, United States; International Center for Polyamine Disorders, Grand Rapids, MI, United States.
Elizabeth A VanSickleInternational Center for Polyamine Disorders, Grand Rapids, MI, United States; Division of Medical Genetics, Corewell Health/Helen DeVos Children's Hospital, Grand Rapids, MI, United States.
Caleb P BuppDepartment of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, United States; International Center for Polyamine Disorders, Grand Rapids, MI, United States; Division of Medical Genetics, Corewell Health/Helen DeVos Children's Hospital, Grand Rapids, MI, United States.
André S BachmannDepartment of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, United States; International Center for Polyamine Disorders, Grand Rapids, MI, United States. Electronic address: bachma26@msu.edu.

Funding

Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disordersR01HD110500 · NICHD · MICHIGAN STATE UNIVERSITY · PI ANDRE S BACHMANN, Caleb Bupp · 2023 to 2026
$2.7M
NICHD NIH HHS R01 HD110500
6 · The paper itself

Abstract

Polyamines are aliphatic molecules that include putrescine, spermidine, and spermine. Polyamines are present in most living organisms including humans. These positively charged molecules play important roles in cell physiology and pathology by contributing to embryonic cell development, regulation of cell division and, if overproduced, the stimulation of cancer cell proliferation and tumorigenesis. We recently discovered Bachmann-Bupp Syndrome (BABS); a rare neurodevelopmental disorder linked to de novo mutations in the ornithine decarboxylase 1 (ODC1) gene. ODC1 gene mutations that are linked to BABS always produce C-terminally truncated versions of the enzyme ornithine decarboxylase (ODC). These shortened ODC proteins remain enzymatically active and are not cleared by the proteasome, therefore leading to ODC protein accumulation in cells. ODC is a key enzyme of polyamine biosynthesis by converting ornithine to putrescine, and if accumulated, can lead to high putrescine levels in human cells including red blood cells (RBCs) and primary dermal fibroblasts. Here we describe how to quantitatively measure ODC enzymatic activity and the polyamines by a radiolabeled

Indexed as

Enzyme AssaysOrnithine DecarboxylasePolyaminesChromatography, High Pressure LiquidFibroblastsHumansMutationPutrescineOrnithine DecarboxylasePolyaminesPutrescine(14)C ornithineDFMOHPLCOrnithine decarboxylase (ODC)Polyamine detectionRadiolabeled enzymatic ODC activity assayRed blood cells

Identifiers

PMID40382142
PMCPMC12646276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.